[HNICPantitude]

Canadian Pharmaceutical companies are incapable, in their current state, to handle the volume which they would be bombarded with by increasing their demand tenfold. This type of demand simply can not be met. Additionally, U.S. pharmaceutical companies spend a tremendous amount of money on both R&D and FDA Approvals to take their drugs to market. Then, and only then do a majority of "knock-offs" or generics come to be manufactured in other countries at a cheaper rate. This is simply due to the incredible cost of approval. Aside from cost, placing this type of financial pressure on U.S. pharmaceutical companies will slow down this research and lead to slower progress in medicine in general.